In a study performed on relapsed/refractory classical Hodgkin's lymphoma, in addition to the positivity for PD-L1, high surface expression of HLA class II molecules also correlated with a better response to the anti PD-1 monoclonal antibody nivolumab (47). Here, CD274 is linked to Hodgkins lymphoma.